Javascript must be enabled to continue!
Epidemiology of Hepatitis B Virus infection: Prevalence, vaccine coverage and its barriers in Katagum Local Government Area, Bauchi State Nigeria
View through CrossRef
Hepatitis B Virus (HBV) remains a major global health challenge, particularly in developing countries where vaccination coverage is low. This study aimed to assess the prevalence of HBV infection, knowledge, attitudes, and vaccine uptake among patients in Katagum Local Government Area Bauchi State, Nigeria. A total of 385 patients were recruited for the study. Blood samples were collected and tested for HBV surface antigen (HbsAg) using a rapid detection kit. Demographic data, vaccination status, and knowledge of HBV were obtained through structured questionnaires. Data were analyzed using descriptive and inferential statistics. The overall prevalence of HBV was 3.9%, with a higher rate in males (2.6%) compared to females (1.3%). Adults aged 25–64 years had the highest prevalence (2.6%), while no cases were recorded among individuals above 65 years. Rural residents had a higher prevalence (2.34%) than urban residents (1.56%). Vaccination coverage was 43.38%, with higher uptake among urban residents (23.38%) and males (35.06%). Marital status (p = 0.049) and place of residence (p = 0.000) were significantly associated with vaccine uptake. Knowledge of HBV was significantly linked to vaccination status (p = 0.031), as were attitudes toward the disease and its prevention (p < 0.001). The main barriers to vaccination were lack of awareness (42.20%), fear of side effects (22.94%), and negative attitudes toward vaccination (20.64%). The study highlighted a moderate HBV prevalence and suboptimal vaccination coverage in Katagum LGA, Bauchi State. There is a need for intensified awareness campaigns, improved vaccine accessibility, and targeted interventions to increase HBV vaccination rates, particularly in rural areas and among vulnerable groups.
African Journals Online (AJOL)
Title: Epidemiology of Hepatitis B Virus infection: Prevalence, vaccine coverage and its barriers in Katagum Local Government Area, Bauchi State Nigeria
Description:
Hepatitis B Virus (HBV) remains a major global health challenge, particularly in developing countries where vaccination coverage is low.
This study aimed to assess the prevalence of HBV infection, knowledge, attitudes, and vaccine uptake among patients in Katagum Local Government Area Bauchi State, Nigeria.
A total of 385 patients were recruited for the study.
Blood samples were collected and tested for HBV surface antigen (HbsAg) using a rapid detection kit.
Demographic data, vaccination status, and knowledge of HBV were obtained through structured questionnaires.
Data were analyzed using descriptive and inferential statistics.
The overall prevalence of HBV was 3.
9%, with a higher rate in males (2.
6%) compared to females (1.
3%).
Adults aged 25–64 years had the highest prevalence (2.
6%), while no cases were recorded among individuals above 65 years.
Rural residents had a higher prevalence (2.
34%) than urban residents (1.
56%).
Vaccination coverage was 43.
38%, with higher uptake among urban residents (23.
38%) and males (35.
06%).
Marital status (p = 0.
049) and place of residence (p = 0.
000) were significantly associated with vaccine uptake.
Knowledge of HBV was significantly linked to vaccination status (p = 0.
031), as were attitudes toward the disease and its prevention (p < 0.
001).
The main barriers to vaccination were lack of awareness (42.
20%), fear of side effects (22.
94%), and negative attitudes toward vaccination (20.
64%).
The study highlighted a moderate HBV prevalence and suboptimal vaccination coverage in Katagum LGA, Bauchi State.
There is a need for intensified awareness campaigns, improved vaccine accessibility, and targeted interventions to increase HBV vaccination rates, particularly in rural areas and among vulnerable groups.
.
Related Results
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
Potable Water Sources, Household Hygiene, and Sanitation Practices in Ikpoba Okha LGA, Edo State: Implications for Public Health and Sustainable Water Management
Omoregie, Andrew Edosa.1 Omoregie Abieyuwa Peace2 Okoro, Enyinnaya Okoro.3
1 College of Medi
Potable Water Sources, Household Hygiene, and Sanitation Practices in Ikpoba Okha LGA, Edo State: Implications for Public Health and Sustainable Water Management
Omoregie, Andrew Edosa.1 Omoregie Abieyuwa Peace2 Okoro, Enyinnaya Okoro.3
1 College of Medi
BACKGROUND
Access to potable drinking water and sufficient sanitation continues to be an urgent global concern, particularly in developing regions where con...
IgM antibody to hepatitis C virus in acute and chronic hepatitis C
IgM antibody to hepatitis C virus in acute and chronic hepatitis C
To assess possible role of testing for IgM-specific antibody in the diagnosis and monitoring of patients with hepatitis C, we tested sera from 14 patients with acute and 97 patient...
Interactions Between Human Immunodeficiency Virus–1, Hepatitis Delta Virus and Hepatitis B Virus Infections in 260 Chronic Carriers of Hepatitis B Virus
Interactions Between Human Immunodeficiency Virus–1, Hepatitis Delta Virus and Hepatitis B Virus Infections in 260 Chronic Carriers of Hepatitis B Virus
To evaluate the factors determining the severity of chronic hepatitis B virus infection and the interactions of human immunodeficiency virus and hepatitis delta virus infections, w...
Burden of the Beast
Burden of the Beast
Introduction
Throughout the COVID-19 pandemic, and its fluctuating waves of infections and the emergence of new variants, Indigenous populations in Australia and worldwide have re...
Prevalence of Hepatitis C Virus Infection in Hemodialysis Patients: A Longitudinal Study Comparing the Results of RNA and Antibody Assays
Prevalence of Hepatitis C Virus Infection in Hemodialysis Patients: A Longitudinal Study Comparing the Results of RNA and Antibody Assays
We longitudinally studied 51 patients from two hemodialysis centers to determine the prevalence of hepatitis C virus infection in hemodialysis patients. Serum samples were tested f...
Infections of Hepatitis B and C and Malaria Plasmodium Falciparum among Blood Donors in Ife East Local Government Area, Ile Ife, Osun State, Nigeria
Infections of Hepatitis B and C and Malaria Plasmodium Falciparum among Blood Donors in Ife East Local Government Area, Ile Ife, Osun State, Nigeria
Endemic regions for malaria are endemic for other infectious diseases that might affect the malaria infection. Infection with
hepatitis B virus (HBV) and hepatitis C virus (HCV) ar...
Seroprevalence and clinical outcome of hepatitis D infection in Qatar
Seroprevalence and clinical outcome of hepatitis D infection in Qatar
Background: Worldwide, 5–10% of people with chronic hepatitis B virus infection are co-infected with hepatitis D virus. In Qatar, there are no data on hepatitis D virus infection a...

